» Articles » PMID: 23093109

Colorectal Carcinoma Grading by Quantifying Poorly Differentiated Cell Clusters is More Reproducible and Provides More Robust Prognostic Information Than Conventional Grading

Overview
Journal Virchows Arch
Date 2012 Oct 25
PMID 23093109
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The most widely used system to define the histological grade of colorectal carcinoma (CRC) is based on the degree of gland formation. This system suffers from significant interobserver variability which may limit its prognostic value and consequently better standardized criteria for the assessment of histological grading of CRC are needed. The present study aims to evaluate and to compare, in a cohort of postsurgical pTNM stage I CRC, conventional histological grading, and a novel grading system based on the number of poorly differentiated clusters of neoplastic cells, in terms of interobserver reproducibility, prognostic significance on progression-free survival, and association with other clinicopathological characteristics. Grading with both systems was performed by two pathologists independently and blinded to the clinicopathological data. Interobserver agreement was higher when grade was assessed by counting poorly differentiated clusters than by assessing the relative proportion of the glandular component. Contrary to conventional grading, the novel system provided significant prognostic information in terms of progression-free survival and was significantly associated with budding, invasive growth, lymphatic invasion, and occult nodal metastases of CRC. In conclusion, our findings suggest that a tumor grading system based on the number of poorly differentiated clusters is more reproducible and provides better prognostic stratification of pTNM stage I CRC patients than conventional grading.

Citing Articles

Evaluation of Applicability of Tumor Budding and Poorly Differentiated Clusters as Additional Prognostic Markers in Colorectal Cancers.

Sarkar S, Guha R, Chakrabarti S South Asian J Cancer. 2025; 13(4):315-319.

PMID: 40060345 PMC: 11888805. DOI: 10.1055/s-0044-1788050.


Refining Risk Criteria May Substantially Reduce Unnecessary Additional Surgeries after Local Resection of T1 Colorectal Cancer.

Martinez de Juan F, Navarro S, Machado I Cancers (Basel). 2024; 16(13).

PMID: 39001382 PMC: 11240655. DOI: 10.3390/cancers16132321.


Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology.

Pontarollo G, Bonjour M, Walter T, Pioche M, Lavrut P, Rabeyrin M Virchows Arch. 2024; 485(2):233-244.

PMID: 38273213 PMC: 11329611. DOI: 10.1007/s00428-023-03722-3.


Grades of Poorly Differentiated Clusters are Associated with Lymph Node and the Tumour, Node and Metastasis Stages in Colorectal Carcinoma.

Kerisnon Krishnan T, Mohtarrudin N, Wan Yaacob W, Hussin H Malays J Med Sci. 2024; 30(6):70-78.

PMID: 38239248 PMC: 10793141. DOI: 10.21315/mjms2023.30.6.8.


Colorectal Carcinomas: Searching for New Histological Parameters Associated with Lymph Node Metastases.

Jurescu A, Vaduva A, Vita O, Gheju A, Cornea R, Lazureanu C Medicina (Kaunas). 2023; 59(10).

PMID: 37893479 PMC: 10608479. DOI: 10.3390/medicina59101761.


References
1.
Barresi V, Di Gregorio C, Reggiani-Bonetti L, Ieni A, Ponz-De Leon M, Barresi G . Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?. Hum Pathol. 2011; 42(11):1720-6. DOI: 10.1016/j.humpath.2010.05.031. View

2.
Landis S, Murray T, Bolden S, Wingo P . Cancer statistics, 1999. CA Cancer J Clin. 1999; 49(1):8-31, 1. DOI: 10.3322/canjclin.49.1.8. View

3.
Nicastri D, Doucette J, Godfrey T, Hughes S . Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn. 2007; 9(5):563-71. PMC: 2049052. DOI: 10.2353/jmoldx.2007.070032. View

4.
Reggiani Bonetti L, Di Gregorio C, de Gaetani C, Pezzi A, Barresi G, Barresi V . Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma. Scand J Gastroenterol. 2011; 46(7-8):881-6. DOI: 10.3109/00365521.2011.571708. View

5.
Ueno H, Mochizuki H, Hashiguchi Y, Ishikawa K, Fujimoto H, Shinto E . Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg. 2003; 239(1):34-42. PMC: 1356190. DOI: 10.1097/01.sla.0000103070.13030.eb. View